RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Assembly Biosciences Stock

Assembly Biosciences Liabilities 2024

Assembly Biosciences Liabilities

95.73 M USD

Ticker

ASMB

ISIN

US0453961080

WKN

A117S1

In 2024, Assembly Biosciences's total liabilities amounted to 95.73 M USD, a 400.4% difference from the 19.13 M USD total liabilities in the previous year.

Assembly Biosciences Aktienanalyse

What does Assembly Biosciences do?

Assembly Biosciences Inc is an innovative biotechnology company specializing in the development of new therapies for infectious diseases and gastrointestinal disorders. The company was founded in 2005 and is headquartered in South San Francisco, California. The company's business model focuses on the discovery and development of new drugs for infectious diseases and gastrointestinal disorders, with a goal of establishing a strong pipeline of innovative therapeutics. The company's research activities are divided into two main areas: infectious diseases and gastrointestinal disorders. The company currently has no products on the market but is in the development phase of its pipeline. Assembly Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Assembly Biosciences's Liabilities

Assembly Biosciences's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Assembly Biosciences's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Assembly Biosciences's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Assembly Biosciences's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Assembly Biosciences’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Assembly Biosciences stock

What is the level of liabilities of Assembly Biosciences this year?

Assembly Biosciences has a debt balance of 95.73 M USD this year.

What were the liabilities of Assembly Biosciences compared to the previous year?

The liabilities of Assembly Biosciences have increased by 400.4% increased compared to the previous year.

What are the consequences of high debt for investors of Assembly Biosciences?

High liabilities can pose a risk for investors of Assembly Biosciences, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Assembly Biosciences?

Low liabilities mean that Assembly Biosciences has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Assembly Biosciences affect the company?

An increase in liabilities of Assembly Biosciences can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Assembly Biosciences affect the company?

A decrease in the liabilities of Assembly Biosciences can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Assembly Biosciences?

Some factors that can influence the liabilities of Assembly Biosciences include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Assembly Biosciences so important for investors?

The liabilities of Assembly Biosciences are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Assembly Biosciences take to modify the liabilities?

To change its liabilities, Assembly Biosciences can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Assembly Biosciences pay?

Over the past 12 months, Assembly Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Assembly Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Assembly Biosciences?

The current dividend yield of Assembly Biosciences is .

When does Assembly Biosciences pay dividends?

Assembly Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Assembly Biosciences?

Assembly Biosciences paid dividends every year for the past 0 years.

What is the dividend of Assembly Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Assembly Biosciences located?

Assembly Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Assembly Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Assembly Biosciences from 12/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/1/2024.

When did Assembly Biosciences pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Assembly Biosciences in the year 2023?

In the year 2023, Assembly Biosciences distributed 0 USD as dividends.

In which currency does Assembly Biosciences pay out the dividend?

The dividends of Assembly Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Assembly Biosciences

Our stock analysis for Assembly Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Assembly Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.